Prevention.com—May 11, 2012
A new FDA study finds that taking anti-bone-loss drugs like Fosamax long-term isn’t all it’s cracked up to be.
“There is clear evidence that these drugs reduce the risk of spinal and hip fractures,” says Linda A. Russell, M.D., a rheumatologist at Hospital for Special Surgery. “But when a patient has been on the drug for 3-5 years, you have to look at whether they still need it, or if they should take a holiday.”
Read the full story at Prevention.com.